首页 | 本学科首页   官方微博 | 高级检索  
     

非小细胞肺癌患者血清人类表皮生长因子受体-2和环氧化酶-2水平及临床意义
引用本文:陈为军,仲昭坤,张恩宁,周冬梅,杨喜凤. 非小细胞肺癌患者血清人类表皮生长因子受体-2和环氧化酶-2水平及临床意义[J]. 河南诊断与治疗杂志, 2013, 0(10): 959-961
作者姓名:陈为军  仲昭坤  张恩宁  周冬梅  杨喜凤
作者单位:烟台市烟台山医院肿瘤内科,山东烟台264000
基金项目:烟台市科技局基金项目(20091563).
摘    要:目的探讨非小细胞肺癌患者血清人类表皮生长因子受体2(humanepidermalgrowthfactorreceptor2,HER2)和环氧化酶2(cycl00xygenase-2,COX2)水平相关性及与预后的关系。方法非小细胞肺癌患者221例(观察组)与肺部良性疾病患者41例(对照组),2组采用双抗体夹心ELISA法检测血清HER2和COX2水平,分析二者相关性及与生存时间的关系。结果观察组HER-2和COX-2水平明显高于对照组(P〈0.05);观察组HER2阳性表达者中位生存时间(48.7周)较HER-2阴性表达者(62.3周)短;COX2阳性表达者中位生存时间(67.0周)较COX-2阴性表达者(83.1周)短(P〈0.05);观察组HER2与CoX2水平呈正相关(r=0.717,P=0.007);观察组HER-2和COX-2水平不是影响预后的独立危险因素,但二者联合检测可预测患者预后(OR=1.5,95%CI:1.08~2.09)。结论非小细胞肺癌与HER-2和COX2阳性表达明显相关,二者联合检测有助于非小细胞肺癌的预后评估。

关 键 词:非小细胞肺癌  人类表皮生长因子受体-2  环氧化酶-2  ELISA

Correlation between human epidermal growth factor receptor-2 and cyclooxygenase-2 in patients with non-small cell lung cancer and clinical significance
CHEN Wei-jun,ZHONG Zhao kun,ZHANG En-ning,ZHOU Dong-mei,YANG Xi-feng. Correlation between human epidermal growth factor receptor-2 and cyclooxygenase-2 in patients with non-small cell lung cancer and clinical significance[J]. Henan Journal of Diagnosis and Therapy, 2013, 0(10): 959-961
Authors:CHEN Wei-jun  ZHONG Zhao kun  ZHANG En-ning  ZHOU Dong-mei  YANG Xi-feng
Affiliation:(Department of Medical Oncology, Yantaishan Hospital of Yantai, Yantai 264000, China)
Abstract:Objective To explore the correlation between serum human epidermal growth factor receptor 2 (HER 2) and cyclooxygenase-2 (COX-2) as well as their relationship with the prognosis in patients with non small cell lung cancer (NSCLC). Methods The levels of HER-2 and COX-2 were detected by using ELISA technique in 221 NSCLC patients (observation group) and 41 patients with benign lung disease (control group), and were analyzed their correlation. The relationship of HER-Z and COX-2 with the suevival time was also analyzed. Results The levels of serum HER 2 and COX 2 were significantly higher in observation group than those in control group (P〈0.05). The median survival time in the patients with positive HER-2 expression was 48.7 weeks, shorter than that in those with negative HER-2 expression (62.3 weeks), and the median survival time in the patients with positive COX 2 expression was 67.0 weeks, shorter than that in those with negative COX 2 expression (83. 1 weeks) (P〈0.05). HER-2 level was positively correlated with COX-2 level in observation group (r=0. 717, P =0. 007), and both of them were not the independent risk factors for the prognosis. The combined detection could predict the prognosis (OR= 1. 5, 95;CI: 1. 08 to 2. 09). Conclusion The positive expression of HER-2 is obviously correlated with the positive expression of COX-2 in NSCLC patients, and the combined detection of them may be of important value in the judgment of prognosis.
Keywords:Non small cell lung cancer  human epidermal growth factor receptor-2  cyclooxygenase 2  ELISA
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号